Pressure Guidewires Market Size to Hit USD 1,293.34 Million by 2034

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Pressure Guidewires Market

5.1. COVID-19 Landscape: Pressure Guidewires Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Pressure Guidewires Market, By Product Type

8.1. Pressure Guidewires Market Revenue and Volume, by Product Type

8.1.1. Pressure-Only Guidewires

8.1.1.1. Market Revenue and Volume Forecast

8.1.2. Pressure + Flow Guidewires (Hybrid)

8.1.2.1. Market Revenue and Volume Forecast

8.1.3. Wireless Pressure Guidewires

8.1.3.1. Market Revenue and Volume Forecast

8.1.4. Others

8.1.4.1. Market Revenue and Volume Forecast

Chapter 9. Global Pressure Guidewires Market, By Technology

9.1. Pressure Guidewires Market Revenue and Volume, by Technology

9.1.1. Fiber Optic Pressure Sensors

9.1.1.1. Market Revenue and Volume Forecast

9.1.2. Solid-State Pressure Sensors

9.1.2.1. Market Revenue and Volume Forecast

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast

Chapter 10. Global Pressure Guidewires Market, By Lesion Type

10.1. Pressure Guidewires Market Revenue and Volume, by Lesion Type

10.1.1. Complex Lesions

10.1.1.1. Market Revenue and Volume Forecast

10.1.2. Simple Lesions

10.1.2.1. Market Revenue and Volume Forecast

10.1.5. Others

10.1.5.1. Market Revenue and Volume Forecast

Chapter 11. Global Pressure Guidewires Market, By End Use

11.1. Pressure Guidewires Market Revenue and Volume, by End Use

11.1.1. Hospitals

11.1.1.1. Market Revenue and Volume Forecast

11.1.2. Cardiac Catheterization Laboratories

11.1.2.1. Market Revenue and Volume Forecast

11.1.3. Specialty Cardiac Centers

11.1.3.1. Market Revenue and Volume Forecast

11.1.4. Ambulatory Surgical Centers

11.1.4.1. Market Revenue and Volume Forecast

11.1.5. Others

11.1.5.1. Market Revenue and Volume Forecast

Chapter 12. Global Pressure Guidewires Market, By Distribution Channel

12.1. Pressure Guidewires Market Revenue and Volume, by Distribution Channel

12.1.1. Direct Sales (Institutional Procurement)

12.1.1.1. Market Revenue and Volume Forecast

12.1.2. Third-Party Distributors

12.1.2.1. Market Revenue and Volume Forecast

12.1.3. Online Medical Platforms

12.1.3.1. Market Revenue and Volume Forecast

12.1.4. Others

12.1.4.1. Market Revenue and Volume Forecast

Chapter 13. Global Pressure Guidewires Market, Regional Estimates and Trend Forecast

13.1. North America

13.1.1. Market Revenue and Volume Forecast, by Product Type

13.1.2. Market Revenue and Volume Forecast, by Technology

13.1.3. Market Revenue and Volume Forecast, by Lesion Type

13.1.4. Market Revenue and Volume Forecast, by End Use

13.1.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.6. U.S.

13.1.6.1. Market Revenue and Volume Forecast, by Product Type

13.1.6.2. Market Revenue and Volume Forecast, by Technology

13.1.6.3. Market Revenue and Volume Forecast, by Lesion Type

13.1.6.4. Market Revenue and Volume Forecast, by End Use

13.1.6.5. Market Revenue and Volume Forecast, by Distribution Channel

13.1.7. Rest of North America

13.1.7.1. Market Revenue and Volume Forecast, by Product Type

13.1.7.2. Market Revenue and Volume Forecast, by Technology

13.1.7.3. Market Revenue and Volume Forecast, by Lesion Type

13.1.7.4. Market Revenue and Volume Forecast, by End Use

13.1.7.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2. Europe

13.2.1. Market Revenue and Volume Forecast, by Product Type

13.2.2. Market Revenue and Volume Forecast, by Technology

13.2.3. Market Revenue and Volume Forecast, by Lesion Type

13.2.4. Market Revenue and Volume Forecast, by End Use

13.2.5. Market Revenue and Volume Forecast, by Distribution Channel

13.2.6. UK

13.2.6.1. Market Revenue and Volume Forecast, by Product Type

13.2.6.2. Market Revenue and Volume Forecast, by Technology

13.2.6.3. Market Revenue and Volume Forecast, by Lesion Type

13.2.7. Market Revenue and Volume Forecast, by End Use

13.2.8. Market Revenue and Volume Forecast, by Distribution Channel

13.2.9. Germany

13.2.9.1. Market Revenue and Volume Forecast, by Product Type

13.2.9.2. Market Revenue and Volume Forecast, by Technology

13.2.9.3. Market Revenue and Volume Forecast, by Lesion Type

13.2.10. Market Revenue and Volume Forecast, by End Use

13.2.11. Market Revenue and Volume Forecast, by Distribution Channel

13.2.12. France

13.2.12.1. Market Revenue and Volume Forecast, by Product Type

13.2.12.2. Market Revenue and Volume Forecast, by Technology

13.2.12.3. Market Revenue and Volume Forecast, by Lesion Type

13.2.12.4. Market Revenue and Volume Forecast, by End Use

13.2.13. Market Revenue and Volume Forecast, by Distribution Channel

13.2.14. Rest of Europe

13.2.14.1. Market Revenue and Volume Forecast, by Product Type

13.2.14.2. Market Revenue and Volume Forecast, by Technology

13.2.14.3. Market Revenue and Volume Forecast, by Lesion Type

13.2.14.4. Market Revenue and Volume Forecast, by End Use

13.2.15. Market Revenue and Volume Forecast, by Distribution Channel

13.3. APAC

13.3.1. Market Revenue and Volume Forecast, by Product Type

13.3.2. Market Revenue and Volume Forecast, by Technology

13.3.3. Market Revenue and Volume Forecast, by Lesion Type

13.3.4. Market Revenue and Volume Forecast, by End Use

13.3.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.6. India

13.3.6.1. Market Revenue and Volume Forecast, by Product Type

13.3.6.2. Market Revenue and Volume Forecast, by Technology

13.3.6.3. Market Revenue and Volume Forecast, by Lesion Type

13.3.6.4. Market Revenue and Volume Forecast, by End Use

13.3.7. Market Revenue and Volume Forecast, by Distribution Channel

13.3.8. China

13.3.8.1. Market Revenue and Volume Forecast, by Product Type

13.3.8.2. Market Revenue and Volume Forecast, by Technology

13.3.8.3. Market Revenue and Volume Forecast, by Lesion Type

13.3.8.4. Market Revenue and Volume Forecast, by End Use

13.3.9. Market Revenue and Volume Forecast, by Distribution Channel

13.3.10. Japan

13.3.10.1. Market Revenue and Volume Forecast, by Product Type

13.3.10.2. Market Revenue and Volume Forecast, by Technology

13.3.10.3. Market Revenue and Volume Forecast, by Lesion Type

13.3.10.4. Market Revenue and Volume Forecast, by End Use

13.3.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.3.11. Rest of APAC

13.3.11.1. Market Revenue and Volume Forecast, by Product Type

13.3.11.2. Market Revenue and Volume Forecast, by Technology

13.3.11.3. Market Revenue and Volume Forecast, by Lesion Type

13.3.11.4. Market Revenue and Volume Forecast, by End Use

13.3.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4. MEA

13.4.1. Market Revenue and Volume Forecast, by Product Type

13.4.2. Market Revenue and Volume Forecast, by Technology

13.4.3. Market Revenue and Volume Forecast, by Lesion Type

13.4.4. Market Revenue and Volume Forecast, by End Use

13.4.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.6. GCC

13.4.6.1. Market Revenue and Volume Forecast, by Product Type

13.4.6.2. Market Revenue and Volume Forecast, by Technology

13.4.6.3. Market Revenue and Volume Forecast, by Lesion Type

13.4.6.4. Market Revenue and Volume Forecast, by End Use

13.4.7. Market Revenue and Volume Forecast, by Distribution Channel

13.4.8. North Africa

13.4.8.1. Market Revenue and Volume Forecast, by Product Type

13.4.8.2. Market Revenue and Volume Forecast, by Technology

13.4.8.3. Market Revenue and Volume Forecast, by Lesion Type

13.4.8.4. Market Revenue and Volume Forecast, by End Use

13.4.9. Market Revenue and Volume Forecast, by Distribution Channel

13.4.10. South Africa

13.4.10.1. Market Revenue and Volume Forecast, by Product Type

13.4.10.2. Market Revenue and Volume Forecast, by Technology

13.4.10.3. Market Revenue and Volume Forecast, by Lesion Type

13.4.10.4. Market Revenue and Volume Forecast, by End Use

13.4.10.5. Market Revenue and Volume Forecast, by Distribution Channel

13.4.11. Rest of MEA

13.4.11.1. Market Revenue and Volume Forecast, by Product Type

13.4.11.2. Market Revenue and Volume Forecast, by Technology

13.4.11.3. Market Revenue and Volume Forecast, by Lesion Type

13.4.11.4. Market Revenue and Volume Forecast, by End Use

13.4.11.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5. Latin America

13.5.1. Market Revenue and Volume Forecast, by Product Type

13.5.2. Market Revenue and Volume Forecast, by Technology

13.5.3. Market Revenue and Volume Forecast, by Lesion Type

13.5.4. Market Revenue and Volume Forecast, by End Use

13.5.5. Market Revenue and Volume Forecast, by Distribution Channel

13.5.6. Brazil

13.5.6.1. Market Revenue and Volume Forecast, by Product Type

13.5.6.2. Market Revenue and Volume Forecast, by Technology

13.5.6.3. Market Revenue and Volume Forecast, by Lesion Type

13.5.6.4. Market Revenue and Volume Forecast, by End Use

13.5.7. Market Revenue and Volume Forecast, by Distribution Channel

13.5.8. Rest of LATAM

13.5.8.1. Market Revenue and Volume Forecast, by Product Type

13.5.8.2. Market Revenue and Volume Forecast, by Technology

13.5.8.3. Market Revenue and Volume Forecast, by Lesion Type

13.5.8.4. Market Revenue and Volume Forecast, by End Use

13.5.8.5. Market Revenue and Volume Forecast, by Distribution Channel

Chapter 14. Company Profiles

14.1. Abbott Laboratories

14.1.1. Company Overview

14.1.2. Product Offerings

14.1.3. Financial Performance

14.1.4. Recent Initiatives

14.2. Boston Scientific Corporation

14.2.1. Company Overview

14.2.2. Product Offerings

14.2.3. Financial Performance

14.2.4. Recent Initiatives

14.3. Philips Volcano

14.3.1. Company Overview

14.3.2. Product Offerings

14.3.3. Financial Performance

14.3.4. Recent Initiatives

14.4. Terumo Corporation

14.4.1. Company Overview

14.4.2. Product Offerings

14.4.3. Financial Performance

14.4.4. Recent Initiatives

14.5. Opsens Inc.

14.5.1. Company Overview

14.5.2. Product Offerings

14.5.3. Financial Performance

14.5.4. Recent Initiatives

14.6. Acist Medical Systems (Bracco Group)

14.6.1. Company Overview

14.6.2. Product Offerings

14.6.3. Financial Performance

14.6.4. Recent Initiatives

14.7. Merit Medical Systems

14.7.1. Company Overview

14.7.2. Product Offerings

14.7.3. Financial Performance

14.7.4. Recent Initiatives

14.8. Cardiovascular Systems, Inc. (CSI)

14.8.1. Company Overview

14.8.2. Product Offerings

14.8.3. Financial Performance

14.8.4. Recent Initiatives

14.9. Asahi Intecc Co., Ltd.

14.9.1. Company Overview

14.9.2. Product Offerings

14.9.3. Financial Performance

14.9.4. Recent Initiatives

14.10. Biotronik SE & Co. KG

14.10.1. Company Overview

14.10.2. Product Offerings

14.10.3. Financial Performance

14.10.4. Recent Initiatives

Chapter 15. Research Methodology

15.1. Primary Research

15.2. Secondary Research

15.3. Assumptions

Chapter 16. Appendix

16.1. About Us

16.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The pressure guidewires market size is expected to increase from USD 573.48 million in 2024 to USD 1,293.34 million by 2034.

The pressure guidewires market is expected to grow at a compound annual growth rate (CAGR) of around 8.48% from 2025 to 2034.

The major players in the pressure guidewires market include Abbott Laboratories, Boston Scientific Corporation, Philips Volcano, Terumo Corporation, Opsens Inc., Acist Medical Systems (Bracco Group), Merit Medical Systems, Cardiovascular Systems, Inc. (CSI), Asahi Intecc Co., Ltd., Biotronik SE & Co. KG, Medtronic plc, B. Braun Melsungen AG, Nipro Corporation, Lepu Medical Technology, Nihon Kohden Corporation, MicroPort Scientific Corporation, Hexacath, Teleflex Incorporated, Shimadzu Corporation, and iVascular S.L.U.

The driving factors of the pressure guidewires market are the growing demand for accurate and minimally invasive cardiovascular diagnostics.

North America region will lead the global pressure guidewires market during the forecast period 2025 to 2034.